The Diabetic Cardiorenal Nexus

Area of Science:

• Cardiology
• Nephrology
• Metabolic Diseases

Background:

• Cardiorenal syndrome is the end-stage of combined heart and kidney disease.
• Risk factors like diabetes, hypertension, and obesity negatively impact cardiovascular and renal health.
• Despite improved prognosis for some heart conditions, heart failure admissions persist, often with metabolic and renal dysfunction.

Purpose of the Study:

• To review potential common pathophysiologic targets for treating cardiorenal syndrome.
• To identify novel therapeutic strategies beyond current hemodynamic management.
• To explore the synergistic impact of diabetes, kidney, and cardiac dysfunction.

Main Methods:

• Literature review of cardiorenal syndrome pathophysiology.
• Analysis of existing treatment guidelines for related risk factors.
• Exploration of potential targets in cardiomyocyte, nephron, and extracellular matrices.

Main Results:

• Current therapies focus on hemodynamic factors, with limited advances in managing cardiorenal syndrome.
• Diabetes, kidney, and cardiac dysfunction interact synergistically, increasing healthcare costs.
• Animal models focusing on cellular and matrix components may reveal new therapeutic avenues.

Conclusions:

• Additional hemodynamic solutions for cardiorenal syndrome may be insufficient.
• Further research using targeted animal models is crucial for identifying new treatments.
• Addressing common pathophysiologic targets could prevent and ameliorate cardiorenal syndrome.